Procedure
T-PRF
T-PRF is a medical procedure with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
PROCEDURE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
4
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A4 (100.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completednot_applicable
T-prf Versus T-prf and Low-level Laser Stimulation on Bone Healing at Posterior Mandibular Fractures
NCT06970379
completednot_applicable
Fibrin Glue Versus Titanium Platelet-rich Fibrin in Lateral Sinus Lifting
NCT05831267
completednot_applicable
T-PRF Provides Advantages on Periodontal Healing: A Split Mouth Clinical Study
NCT03027050
completednot_applicable
The Effectiveness of Titanium-Prepared Platelet-Rich Fibrin on Angiogenic Biomarkers in Gingival Crevicular Fluid
NCT02692079
Clinical Trials (4)
Showing 4 of 4 trials
NCT06970379Not Applicable
T-prf Versus T-prf and Low-level Laser Stimulation on Bone Healing at Posterior Mandibular Fractures
NCT05831267Not Applicable
Fibrin Glue Versus Titanium Platelet-rich Fibrin in Lateral Sinus Lifting
NCT03027050Not Applicable
T-PRF Provides Advantages on Periodontal Healing: A Split Mouth Clinical Study
NCT02692079Not Applicable
The Effectiveness of Titanium-Prepared Platelet-Rich Fibrin on Angiogenic Biomarkers in Gingival Crevicular Fluid
All 4 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 4